Most patients who have lung cancer will receive radiation therapy at s
ome point during the course of their disease. For patients with non-sm
all-cell lung cancer, radiation therapy is sometimes used after comple
te resection, particularly in patients with lymph node involvement. In
addition, irradiation is commonly used after incomplete resection. In
patients with unresectable non-small-cell lung cancer, radiation ther
apy alone is typically used, although recent studies of a combination
of chemotherapy and radiation therapy, or radiation therapy given in t
wice-daily fractions, have yielded promising results. For patients wit
h small-cell lung cancer who have limited (that is, nonmetastatic) dis
ease, the addition of thoracic radiation therapy to chemotherapy has i
mproved survival over that with chemotherapy only. The role of prophyl
actic cranial irradiation in small-cell lung cancer remains controvers
ial. Radiation therapy has a major role in the management of locally r
ecurrent and metastatic lung cancer. Both the bones and the brain are
common metastatic sites in patients with lung cancer. Radiation therap
y provides effective palliation of symptoms from these and other metas
tatic lesions.